Trust acts to review quality assurance arrangements for local cervical screening testing service

The national cervical screening programme is a vital aid in helping to detect abnormal cells that if left untreated, could develop possibly into cancer, thus providing the small numbers of women involved with a wider range of treatment options than otherwise might be the case.  The Trust was alerted by the regional screening quality assurance reference centre with concerns about the test results it had analysed for samples reported between July 2013 and March 2014 only.  Although in line with national procedures, where every patient’s sample was reviewed by two individual members of the Trust’s specialist cytology screening team, sufficient concern was raised for the Trust to carry out an audit of all the tests that were screened during this nine month period using cytology screening services from other NHS trusts.